热门资讯> 正文

BIO-key重新获得纳斯达克合规性

2026-07-07 20:11

BIO-key International, Inc.(BKYI) 0

BIO-key International (BKYI) announced that trading of its common stock on the Nasdaq Capital Market will resume at the market open on July 8, 2026.
The company regained compliance with Nasdaq's continued listing standards, including minimum bid price and SEC filing requirements.
Compliance was confirmed following a June 16 hearing before a Nasdaq Hearings Panel.
BIO-key will remain under a Discretionary Panel Monitor for one year, through July 6, 2027.

More on BIO-key

BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
BIO-key signals scaling revenue toward $5M-$10M quarterly as it expects Q2 profitability
BIO-key GAAP EPS of -$0.15, revenue of $2.15M misses by $0.05M
Seeking Alpha’s Quant Rating on BIO-key
Historical earnings data for BIO-key

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。